Abstract
Cardiovascular disease accounts for 40% of all deaths among pediatric patients with end-stage renal disease (ESRD). ESRD has a particularly large influence on the cardiovascular system in children, as indicated by the more than 700-fold increased risk of cardiac death in affected individuals compared with healthy children of the same age. The prevalence of ESRD is low in children, however, and, consequently, few cardiac deaths occur. As a result, prospective follow-up studies of cardiac risk factors in the pediatric setting are lacking. Nevertheless, cross-sectional data on cardiac disease in children with ESRD have started to emerge. Arterial medial calcification is more prominent in children than classic atherosclerotic intimal calcification. Current data suggest that endothelial dysfunction appears early in renal failure in children, and is followed by arterial medial calcification. This calcification causes arterial wall stiffening and subsequently left ventricular hypertrophy. High systolic blood pressure and serum concentrations of intact parathyroid hormone, calcium and phosphate, as well as long-term dialysis, seem to be important risk factors for cardiovascular disease in pediatric patients with ESRD. These features are important targets for preventive intervention. This Review summarizes the currently available data on cardiovascular disease in children with renal failure.
Key Points
-
Children with chronic kidney disease or end-stage renal disease have an increased risk of cardiovascular death
-
Sudden cardiac death is the most common cause of cardiovascular death in children with renal failure
-
Arterial medial calcification (which increases arterial stiffness), left ventricular hypertrophy and endothelial dysfunction are prevalent in children with renal failure
-
Several modifiable factors predict cardiovascular abnormalities in children with chronic kidney disease or end-stage renal disease, including hyperphosphatemia, anemia, insufficient blood pressure control, high intake of calcium salts or active vitamin D and high serum levels of intact parathyroid hormone
-
Transplantation and intensified hemodialysis regimens can minimize several of the modifiable risk factors described above
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
McDonald, S.P. & Craig, J. C. Long-term survival of children with end-stage renal disease. N. Engl. J. Med. 350, 2654–2662 (2004).
Groothoff, J. W. et al. Mortality and causes of death of end-stage renal disease in children: a Dutch cohort study. Kidney Int. 61, 621–629 (2002).
Chavers, B. M., Li, S., Collins, A. J. & Herzog, C. A. Cardiovascular disease in pediatric chronic dialysis patients. Kidney Int. 62, 648–653 (2002).
Parekh, R. S., Carroll, C. E., Wolfe, R. A. & Port, F. K. Cardiovascular mortality in children and young adults with end-stage kidney disease. J. Pediatr. 141, 191–197 (2002).
Kavey, R. E. et al. Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation 114, 2710–2738 (2006).
Mitsnefes, M. M. Cardiovascular disease in children with chronic kidney disease. Adv. Chronic Kidney Dis. 12, 397–405 (2005).
Oh, J. et al. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 106, 100–105 (2002).
Foley, R. N., Parfrey, P. S. & Sarnak, M. J. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am. J. Kidney Dis. 32 (Suppl. 3), S112–S119 (2002).
Ross, R. Atherosclerosis—an inflammatory disease. N. Engl. J. Med. 340, 115–126 (1999).
London, G. M. et al. Forearm reactive hyperemia and mortality in end-stage renal disease. Kidney Int. 65, 700–704 (2004).
Zoccali, C. The endothelium as a target in renal diseases. J. Nephrol. 20 (Suppl. 12), S39–S44 (2002).
Johnson, R. C., Leopold, J. A. & Loscalzo, J. Vascular calcification: pathobiological mechanisms and clinical implications. Circ. Res. 99, 1044–1059 (2006).
Choi, J. H. et al. Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure. Arterioscler. Thromb. Vasc. Biol. 24, 1246–1252 (2004).
Werner, N. et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N. Engl. J. Med. 353, 999–1007 (2005).
Jie, K. E., Goossens, M. H., van Oostrom, O., Lilien, M. R. & Verhaar, M. C. Circulating endothelial progenitor cell levels are higher during childhood than in adult life. Atherosclerosis 202, 345–347 (2009).
Civilibal, M. et al. Traditional and “new” cardiovascular risk markers and factors in pediatric dialysis patients. Pediatr. Nephrol. 22, 1021–1029 (2007).
Lilien, M. R. et al. Vascular function in children after renal transplantation. Am. J. Kidney Dis. 41, 684–691 (2003).
Kari, J. A. et al. Physiology and biochemistry of endothelial function in children with chronic renal failure. Kidney Int. 52, 468–472 (1997).
Lilien, M. R., Koomans, H. A. & Schroder, C. H. Hemodialysis acutely impairs endothelial function in children. Pediatr. Nephrol. 20, 200–204 (2007).
Wang, S. et al. Measurement of arginine derivatives in pediatric patients with chronic kidney disease using high-performance liquid chromatography–tandem mass spectrometry. Clin. Chem. Lab. Med. 45, 1305–1312 (2007).
Hussein, G., Bughdady, Y., Kandil, M. E., Bazaraa, H. M. & Taher, H. Doppler assessment of brachial artery flow as a measure of endothelial dysfunction in pediatric chronic renal failure. Pediatr. Nephrol. 23, 2025–2030 (2008).
Wilson, A. C. et al. Flow-mediated vasodilatation of the brachial artery in children with chronic kidney disease. Pediatr. Nephrol. 23, 1297–1302 (2007).
Lilien, M. R., Schroder, C. H., Levtchenko, E. N. & Koomans, H. A. Growth hormone therapy influences endothelial function in children with renal failure. Pediatr. Nephrol. 19, 785–789 (2004).
London, G. M. et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol. Dial. Transplant. 18, 1731–1740 (2003).
Blacher, J. et al. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 99, 2434–2439 (1999).
Tonelli, M., Sacks, F., Pfeffer, M., Gao, Z. & Curhan, G. Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 112, 2627–2633 (2005).
Giachelli, C. M. et al. Vascular calcification and inorganic phosphate. Am. J. Kidney Dis. 38 (Suppl. 1), S34–S37 (2001).
Jono, S . et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ. Res. 87, E10–E17 (2000).
London, G. M., Marchais, S. J., Guérin, A. P. & Métivier, F. Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia. Curr. Opin. Nephrol. Hypertens. 14, 525–531 (2005).
Jourdan, C. et al. Normative values for intima–media thickness and distensibility of large arteries in healthy adolescents. J. Hypertens. 23, 1707–1715 (2007).
Lorenz, M. W., Markus, H. S., Bots, M. L., Rosvall, M. & Sitzer, M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 115, 459–467 (2007).
Covic, A. et al. Increased arterial stiffness in children on haemodialysis. Nephrol. Dial. Transplant. 21, 729–735 (2006).
Shroff, R. C. et al. Mineral metabolism and vascular damage in children on dialysis. J. Am. Soc. Nephrol. 18, 2996–3003 (2007).
Groothoff, J. W. et al. Increased arterial stiffness in young adults with end-stage renal disease since childhood. J. Am. Soc. Nephrol. 13, 2953–2961 (2002).
Litwin, M. et al. Altered morphologic properties of large arteries in children with chronic renal failure and after renal transplantation. J. Am. Soc. Nephrol. 16, 1494–1500 (2005).
Mitsnefes, M. M. et al. Cardiac and vascular adaptation in pediatric patients with chronic kidney disease: role of calcium-phosphorus metabolism. J. Am. Soc. Nephrol. 16, 2796–2803 (2005).
Litwin, M. et al. Evolution of large-vessel arteriopathy in paediatric patients with chronic kidney disease. Nephrol. Dial. Transplant. 23, 2552–2557 (2008).
Goodman, W. G. et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N. Engl. J. Med. 342, 1478–1483 (2000).
Civilibal, M. et al. Coronary artery calcifications in children with end-stage renal disease. Pediatr. Nephrol. 21, 1426–1433 (2006).
Amann, K., Breitbach, M., Ritz, E. & Mall, G. Myocyte/capillary mismatch in the heart of uremic patients. J. Am. Soc. Nephrol. 9, 1018–1022 (1998).
Mall, G., Huther, W, Schneider, J., Lundin, P. & Ritz, E. Diffuse intermyocardiocytic fibrosis in uraemic patients. Nephrol. Dial. Transplant. 5, 39–44 (1990).
Bosch, A., Ulmer, H. E., Keller, H. E., Bonzel, K. E. & Scharer, K. Electrocardiographic monitoring in children with chronic renal failure. Pediatr. Nephrol. 4, 140–144 (1990).
Kocak, G. et al. QT/corrected QT (QTc) intervals and QT/QTc dispersions in children with chronic renal failure. Int. J. Cardiol. 70, 63–67 (1999).
Bakiler, A. R., Yavascan, O., Harputluoglu, N., Kara, O. D. & Aksu, N. Evaluation of aortic stiffness in children with chronic renal failure. Pediatr. Nephrol. 22, 1911–1919 (2007).
Ulinski, T., Genty, J., Viau, C., Tillous-Borde, I. & Deschenes, G. Reduction of left ventricular hypertrophy in children undergoing hemodialysis. Pediatr. Nephrol. 21, 1171–1178 (2006).
Mitsnefes, M. M. et al. Changes in left ventricular mass index in children and adolescents after renal transplantation. Pediatr. Transplant. 5, 279–284 (2001).
Mitsnefes, M. M. et al. Impaired left ventricular diastolic function in children with chronic renal failure. Kidney Int. 65, 1461–1466 (2004).
Mitsnefes, M. M. et al. Progression of left ventricular hypertrophy in children with early chronic kidney disease: 2-year follow-up study. J. Pediatr. 149, 671–675 (2006).
Becker-Cohen, R. et al. Improved left ventricular mass index in children after renal transplantation. Pediatr. Nephrol. 23, 1545–1550 (2008).
Gruppen, M. P. et al. Cardiac disease in young adult patients with end-stage renal disease since childhood: a Dutch cohort study. Kidney Int. 63, 1058–1065 (2003).
Matteucci, M. C. et al. Left ventricular geometry in children with mild to moderate chronic renal insufficiency. J. Am. Soc. Nephrol. 17, 218–226 (2006).
Matteucci, M. C. et al. Left ventricular hypertrophy, treadmill tests, and 24-hour blood pressure in pediatric transplant patients. Kidney Int. 56, 1566–1570 (1999).
Flynn, J. T. et al. Blood pressure in children with chronic kidney disease: a report from the Chronic Kidney Disease in Children study. Hypertension 52, 631–637 (2008).
Bennett-Richards, K. J. et al. Oral L-arginine does not improve endothelial dysfunction in children with chronic renal failure. Kidney Int. 62, 1372–1378 (2002).
Bennett-Richards, K. et al. Does oral folic acid lower total homocysteine levels and improve endothelial function in children with chronic renal failure? Circulation 105, 1810–1815 (2002).
Briese, S., Claus, M. & Querfeld, U. Arterial stiffness in children after renal transplantation. Pediatr. Nephrol. 23, 2241–2245 (2008).
Bilginer, Y. et al. Carotid intima–media thickness in children and young adults with renal transplant: Internal carotid artery vs. common carotid artery. Pediatr. Transplant. 11, 888–894 (2007).
Walsh, M., Culleton, B., Tonelli, M. & Manns, B. A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related quality of life. Kidney Int. 67, 1500–1508 (2005).
Fischbach, M. et al. Daily on-line haemodiafiltration: a pilot trial in children. Nephrol. Dial. Transplant. 19, 2360–2367 (2004).
Muller, D. et al. Intensified hemodialysis regimens: neglected treatment options for children and adolescents. Pediatr. Nephrol. 23, 1729–1736 (2008).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
Marc R. Lilien's department has received an unrestricted research grant from Ferring Pharmaceuticals BV, The Netherlands.
Rights and permissions
About this article
Cite this article
Lilien, M., Groothoff, J. Cardiovascular disease in children with CKD or ESRD. Nat Rev Nephrol 5, 229–235 (2009). https://doi.org/10.1038/nrneph.2009.10
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2009.10
This article is cited by
-
Effect of L-carnitine supplementation on lipid profile and apolipoproteins in children on hemodialysis: a randomized placebo-controlled clinical trial
Pediatric Nephrology (2021)
-
Vascular calcification burden of Chinese patients with chronic kidney disease: methodology of a cohort study
BMC Nephrology (2015)
-
Cardiovascular complications in atypical haemolytic uraemic syndrome
Nature Reviews Nephrology (2014)
-
Echo-Doppler Assessment of the Biophysical Properties of the Aorta in Children With Chronic Kidney Disease
Pediatric Cardiology (2013)
-
Chapter 6: Blood pressure management in children with CKD ND
Kidney International Supplements (2012)